Insider Selling: HealthEquity, Inc. (NASDAQ:HQY) Director Sells 32,500 Shares of Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Evelyn S. Dilsaver sold 32,500 shares of HealthEquity stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the completion of the transaction, the director now owns 32,123 shares of the company’s stock, valued at approximately $2,547,032.67. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded up $1.91 during trading hours on Thursday, reaching $81.63. The stock had a trading volume of 624,725 shares, compared to its average volume of 607,481. The firm has a 50-day moving average of $79.76 and a 200-day moving average of $73.25. The firm has a market cap of $7.00 billion, a price-to-earnings ratio of 124.56, a PEG ratio of 1.34 and a beta of 0.53. HealthEquity, Inc. has a fifty-two week low of $48.86 and a fifty-two week high of $84.49. The company has a current ratio of 4.76, a quick ratio of 4.93 and a debt-to-equity ratio of 0.43.

Hedge Funds Weigh In On HealthEquity

Large investors have recently modified their holdings of the business. PNC Financial Services Group Inc. increased its stake in HealthEquity by 31.8% in the first quarter. PNC Financial Services Group Inc. now owns 13,547 shares of the company’s stock valued at $913,000 after purchasing an additional 3,266 shares during the last quarter. AlphaCrest Capital Management LLC acquired a new position in shares of HealthEquity during the first quarter worth $234,000. Natixis Advisors L.P. acquired a new position in shares of HealthEquity in the first quarter worth about $932,000. Bank of Montreal Can boosted its stake in shares of HealthEquity by 44.5% during the 1st quarter. Bank of Montreal Can now owns 8,218 shares of the company’s stock valued at $553,000 after buying an additional 2,532 shares during the last quarter. Finally, Rhumbline Advisers increased its position in shares of HealthEquity by 2.2% in the 1st quarter. Rhumbline Advisers now owns 231,307 shares of the company’s stock worth $15,599,000 after purchasing an additional 4,880 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts recently issued reports on HQY shares. Raymond James boosted their price target on HealthEquity from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday, December 13th. JPMorgan Chase & Co. lowered their price objective on HealthEquity from $81.00 to $73.00 and set an “overweight” rating for the company in a research report on Friday, December 1st. Royal Bank of Canada upped their target price on HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a research report on Wednesday, March 20th. BTIG Research increased their price objective on shares of HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, March 20th. Finally, KeyCorp boosted their target price on shares of HealthEquity from $85.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, March 22nd. One analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.